ASP Isotopes Inc. Common Stock (ASPI) Stock Analysis & Winston Score
ASP Isotopes is a small company that makes enriched isotopes — special versions of chemical elements used in medicine, nuclear energy, and scientific research. Its main products include isotopes like uranium-235 for nuclear fuel and isotopes used in cancer treatment drugs. The company uses a proprietary laser-based enrichment technology called Aerodynamic Separation Process, which is designed to be cheaper and more efficient than older enrichment methods. ASP Isotopes earns revenue by selling enriched isotopes to customers in the medical, energy, and industrial sectors. It operates primarily in South Africa, where its enrichment facilities are located, and is still in an early commercial stage — which explains why its operating losses are very large relative to its revenue. The key growth driver is scaling up production and winning supply contracts, particularly in the nuclear fuel market, but the main risk is that the company is burning cash and has not yet proven it can produce isotopes profitably at commercial scale.
Winston Score: 20/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (1/30)
- Growth: Mixed (6/20)
- Cash Flow: Weak (0/10)
- Stability: Weak (2/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $3.88
Market Cap: $322M
Sector: Basic Materials
Industry: Chemicals
Exchange: NASDAQ
